Male and Female Stem Cells Derived from One Donor in Scientific First
By Dan Robitzski,
The Scientist
| 12. 22. 2022
Scientists have developed a new line of stem cells—all derived from the same person—that can be used to study sex differences without the confounds of interpersonal genetic differences.
Human induced pluripotent stem cells (hiPSCs), which are cells taken from a person that are then reprogrammed to abandon their current roles and return to a stem cell–like state, have become valuable tools not only for therapeutic purposes but also for probing the genetic mechanisms underlying cell behavior and disease. However, findings drawn from stem cell studies may not be broadly applicable, as the fact that all cells in a given line share the same genetic sequence makes it difficult to generalize discoveries, especially when it comes to investigating potential sex differences.
That’s why a team of scientists led by Benjamin Reubinoff, an embryonic stem cell researcher at the Hadassah Medical Organization in Jerusalem, and MD-PhD student Ithai Waldhorn set out to create a new platform for studying genetic sex differences. As Reubinoff tells The Scientist, “The origin was really to generate a model for studying sex differences, given the...
Related Articles
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Arche Noah, GMWatch | 06.17.2026
The European Parliament has voted for a wide-reaching deregulation of New Genomic Techniques (NGTs). There was no majority for amendments stopping patents on conventionally classically bred plants or NGT plants. “Today’s vote is a missed opportunity to protect Europe’s farmers...